Distinct cytogenetic alterations in squamous intraepithelial lesions of the cervix revealed by laser-assisted microdissection and comparative genomichybridization
M. Aubele et al., Distinct cytogenetic alterations in squamous intraepithelial lesions of the cervix revealed by laser-assisted microdissection and comparative genomichybridization, CANC CYTOP, 84(6), 1998, pp. 375-379
BACKGROUND, It has been established that comparative genomic hybridization
(CGH) on Papanicolaou-stained cervical smears can be used to identify chrom
osomal imbalances,
METHODS. In this study, the authors identified normal and dysplastic squamo
us epithelial cells cytologically: eliminated surrounding bacteria or leuko
cytes by a ultraviolet laser microbeam under microscopic control, and scrap
ed out the cell groups of interest by a microdissection system. In 3 cases
of squamous intraepithelial lesions (SIL), a total of 9 samples of dysplast
ic (n = 6) and nontumorous cells (n = 3) were investigated, each of them co
nsisting of 3-40 cells. The DNA was amplified by degenerate oligonucleotide
primed PCR (DOP-PCR) and used for CGH.
RESULTS, Analyses of all nontumorous cell groups resulted in fluorescence r
atio profiles that showed no deviation from the normal range, confirming th
at no methodologic artefacts have been produced. The CGH profiles from dysp
lastic cells, however, showed various chromosomal imbalances affecting six
to nine different chromosomes. The most frequent gains in DNA were observed
on chromosomes 1p, 2q, 4, and 5, whereas losses were found on chromosomes
6q and 13q.
CONCLUSIONS. The results of this study demonstrate the feasibility and reli
ability of CGH on microdissected cell samples of routinely processed cervic
al smears. To the authors' knowledge, this is the first study reporting the
use of CGH on cervical routine smears. This approach offers the opportunit
y to investigate sequence copy number changes in small, morphologically wel
l-defined groups of dysplastic cells. It may, therefore, serve as a cytogen
etic screening test for identifying chromosomal aberrations in precancerous
lesions that are associated with a high risk for progression to invasive c
ancer. Cancer (Cancer Cytopathol) 1998;84:375-9. (C) 1998 American Cancer S
ociety.